Literature DB >> 20553318

Indexed left atrial volume is a more sensitive indicator of filling pressures and left heart function than is anteroposterior left atrial diameter.

José-Luis Moya-Mur1, Ana García-Martín, Alberto García-Lledó, Soledad Ruiz-Leria, José J Jiménez-Nacher, Alicia Megias-Sanz, Dolores Taboada, Alfonso Muriel.   

Abstract

INTRODUCTION: Left atrial (LA) size is an indicator of the pressure to which it is chronically subjected. Although guidelines recommend measuring it using volume indexed to body surface, the anteroposterior diameter is still normally used. AIM: To evaluate which of these measurements correlates better with atrial pressure-related echocardiographic parameters.
METHODS: Atrial diameter and volume, together with parameters of systolic function, diastolic function, pressure, and degree of mitral regurgitation, were measured in 121 consecutive outpatients.
RESULTS: Atrial diameter correlated with its indexed volume (r: 0.69) with a low degree of agreement for detecting dilation (Kappa: 0.51). Atrial diameter was related to the parameters associated with atrial pressure: E/E' (r: 0.44), pulmonary vein systolic/diastolic rates quotient (r: 0.25) and degree of mitral regurgitation (r: 0.19). The correlations improved when volume indexed to body surface was measured (r: 0.52; 0.38 and 0.44, respectively). In a multiple regression analysis that included E/E', pulmonary vein flow and degree of mitral regurgitation, LA diameter depended entirely on E/E' (r: 0.44; B: 0.04; P: 0.000). The relationship improved when the diameter was corrected for body surface or the volume was measured (r: 0.54 and 0.54, respectively), and in particular when volume indexed to body surface was measured (r: 0.66). In this case, pulmonary vein flow (B: 6.8; P: 0.03), degree of mitral regurgitation (B: 5.2; P: 0.000) and E/E' ratio (B: 0.8; P : 0.000) were included in the equation.
CONCLUSIONS: Indexed atrial volume correlates better with LA pressure surrogates than the anteroposterior diameter, even when this is corrected for body surface.
© 2010, Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20553318     DOI: 10.1111/j.1540-8175.2010.01216.x

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  5 in total

1.  Galectin-3 as a new biomarker of diastolic dysfunction in hemodialysis patients.

Authors:  Ozgul Malcok Gurel; Hakki Yilmaz; Tugrul H Celik; Muzaffer Cakmak; Mehmet Namuslu; Ayse M Bilgiç; Nuket Bavbek; Ali Akcay; Beyhan Eryonucu
Journal:  Herz       Date:  2015-05-20       Impact factor: 1.443

2.  Measurement of Left Atrial Pressure is a Good Predictor of Freedom From Atrial Fibrillation.

Authors:  Leonard Bergau; Dirk Vollmann; Lars Luthje; Jan Martin Sohns; Joachim Seegers; Christian Sohns; Markus Zabel
Journal:  Indian Pacing Electrophysiol J       Date:  2014-07-15

3.  Impaired left ventricular filling in COPD and emphysema: is it the heart or the lungs? The Multi-Ethnic Study of Atherosclerosis COPD Study.

Authors:  Benjamin M Smith; Martin R Prince; Eric A Hoffman; David A Bluemke; Chia-Ying Liu; Dan Rabinowitz; Katja Hueper; Megha A Parikh; Antoinette S Gomes; Erin D Michos; João A C Lima; R Graham Barr
Journal:  Chest       Date:  2013-10       Impact factor: 9.410

4.  Prognostic Utility of Soluble Suppression of Tumorigenicity 2 level as a Predictor of Clinical Outcomes in Incident Hemodialysis Patients.

Authors:  Suk Min Seo; Sun Hwa Kim; Yaeni Kim; Hye Eun Yoon; Seok Joon Shin
Journal:  Int J Med Sci       Date:  2018-05-14       Impact factor: 3.738

5.  Atrial Cardiopathy in the Absence of Atrial Fibrillation Increases Risk of Ischemic Stroke, Incident Atrial Fibrillation, and Mortality and Improves Stroke Risk Prediction.

Authors:  Jodi D Edwards; Jeff S Healey; Jiming Fang; Kathy Yip; David J Gladstone
Journal:  J Am Heart Assoc       Date:  2020-05-20       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.